Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
- Proteomics technologies for the global identification and quantification of proteins
- Targeted metabolomics and mass spectrometry
- Mechanisms of Protein Circular Dichroism: Insights from Computational Modelling
- Fine architecture and mutation mapping of human brain inhibitory system ligand gated ion channels by high-throughput homology modeling
- Positive and Negative Modulation of Nicotinic Receptors
- Sonochemically Born Proteinaceous Micro- and Nanocapsules
Ian A. Brewis and P. Brennan
E. Dudley, M. Yousef, Y. Wang, W.J. Griffiths
Tatyana Karabencheva and Christo Christov
Jonathan G. L. Mullins, Seo-Kyung Chung and Mark I. Rees
Hugo R. Arias
Elena D. Vassileva and Neli S. Koseva
Structural genomics is the systematic determination of 3-D structures of proteins representative of the range of protein structure and function found in nature. The goal is to build a body of structural information that will predict the structure and potential function for almost any protein from knowledge of its coding sequence. This is essential information for understanding the functioning of the human proteome, the ensemble of tens of thousands of proteins specified by the human genome.
While most structural biologists pursue structures of individual proteins or protein groups, specialists in structural genomics pursue structures of proteins on a genome wide scale. This implies large-scale cloning, expression and purification. One main advantage of this approach is economy of scale.
- Examines the three dimensional structure of all proteins of a given organism, by experimental methods such as X-ray crystallography and NMR spectroscopy
- Looks at structural genomics as a foundation of drug discovery as discovering new medicines is becoming more challenging and the pharmaceutical industry is looking to new technologies to help in this mission
Biochemists, biophysicists, cell biologists, protein chemists, structural geneticists, and structural biologists
- No. of pages:
- © Academic Press 2010
- 7th December 2010
- Academic Press
- Hardcover ISBN:
- eBook ISBN:
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principle Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings and given invited plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on development of immunotherapeutics for non-systemic applications.
Swansea University, UK
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.